Real-world treatment strategies and early outcomes in subclavian artery occlusive disease: A single-center experience

The aim of this study was to evaluate treatment strategies and early outcomes in patients undergoing revascularization for symptomatic subclavian artery occlusive disease.

Materials and methods

A retrospective single-center study included 18 consecutive patients treated between January 2021 and December 2024. Demographic, clinical, imaging, procedural, and follow-up data were retrospectively analyzed. Early outcomes were compared according to lesion morphology (stenotic versus occlusive/thrombotic) and clinical presentation.